What we do

isoSolutions Marketing & Management Inc. offers a wide range of products for nuclear medicine applications, from a variety of reliable suppliers, providing a one-stop shopping service as well as technical support.

David

David T. Drummond Managing Director

People matter the most. Every organization should aim to leave people better off. In the health sector that starts with the patient but must also include our suppliers, customers, employees, partners — indeed, everyone whose life is touched by our company.

85

Companies connected
through isoSolutions

350

Orders delivered
worldwide in 2017

94%

Orders delivered
on time in 2017

News

Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas

Posted by Kevin Yang ⎜ Feb 25, 2019

The role of concomitant peptide receptor radionuclide therapy (PRRT) and capecitabine therapy has shown benefit in gastroenteropancreatic neuroendocrine tumors. However, data reporting its role in paraganglioma (PGL) patients is lacking. The aim of this study was to evaluate the role of combined capecitabine and 177Lu-DOTATATE in malignant PGL patients.

keep reading

Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008–2018)

Posted by David T. Drummond ⎜ Feb 21, 2019

Academic journals have published a large number of papers in the therapeutic nuclear medicine (NM) research field in the last 10 years. Despite this, a literature analysis has never before been made to point out the research interest in therapeutic radionuclides (RNs). For this reason, the present study aims specifically to analyze the research output on therapeutic radiometals from 2008 to 2018, with intent to quantify and identify global trends in scientific literature and emphasize the interdisciplinary nature of this research field.

keep reading

Calendar

Apr 1 to 5

11th International Symposium on Targeted-Alpha-Therapy, 2019

11th International Symposium on Targeted-Alpha-Therapy, April 1-5, 2019 in Ottawa, Ontario, Canada. isoSolutions is pleased to inform you that we will attend the 11th International Symposium on Targeted-Alpha-Therapy (TAT11). You can find us at booth 28 the Exhibit Hall at the Fairmont Chateau Laurier.

Nov 13 to 16

ALASBIMN 2019 Annual Meeting

isoSolutions will be attending the ALASBIMN 2019 Annual Meeting to be held in Lima, Peru November 13 to 16, 2019. Marvin Calderon, Regional Sales and Marketing Manager Sales for Latin America hopes to see you there. If you would like to arrange a time and place to meet him, please contact mcalderon@isosolutions.com.

Feb 07 to 09

CANM 2019 Annual Meeting

isoSolutions will be attending the CANM 2019 Annual Meeting to be held in Québec, QC, Canada February 07 to 09, 2019. Pat Acton, Regional Sales and Marketing Manager Sales for Canada and US hopes to see you there. If you would like to arrange a time and place to meet her, please contact pacton@isosolutions.com.

Partners

Elysia Raytest
iThemba
Micro-Rad
SWE
RE
Nukem
RadQual
IDB
Ora
Stracotek
Stracotek

Communities

SNMMI
SNMMI
SNMMI
CNEN